ATE67676T1 - Medikamentoese behandlungen. - Google Patents

Medikamentoese behandlungen.

Info

Publication number: ATE67676T1
Authority: AT; Austria
Prior art keywords: medicational; treatments; metabolites; series; fatty acid
Prior art date: 1985-09-13

Application number

AT86306823T

Other languages

English (en)

Inventor

David Frederick Horrobin

Meadows Woodbridge

Original Assignee

Efamol Holdings

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-09-13

Filing date

1986-09-03

Publication date

1991-10-15

1986-09-03 Application filed by Efamol Holdings filed Critical Efamol Holdings

1991-10-15 Application granted granted Critical

1991-10-15 Publication of ATE67676T1 publication Critical patent/ATE67676T1/de

Links

238000011282 treatment Methods 0.000 title 1
MITFXPHMIHQXPI-UHFFFAOYSA-N Oraflex Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 abstract 2
DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract 2
239000002207 metabolite Substances 0.000 abstract 2
OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 abstract 1
206010070834 Sensitisation Diseases 0.000 abstract 1
239000004098 Tetracycline Substances 0.000 abstract 1
235000020661 alpha-linolenic acid Nutrition 0.000 abstract 1
229960005430 benoxaprofen Drugs 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
235000004626 essential fatty acids Nutrition 0.000 abstract 1
235000020778 linoleic acid Nutrition 0.000 abstract 1
OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract 1
229960004488 linolenic acid Drugs 0.000 abstract 1
235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract 1
150000004032 porphyrins Chemical class 0.000 abstract 1
230000001235 sensitizing effect Effects 0.000 abstract 1
229960002180 tetracycline Drugs 0.000 abstract 1
229930101283 tetracycline Natural products 0.000 abstract 1
235000019364 tetracycline Nutrition 0.000 abstract 1
150000003522 tetracyclines Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT86306823T 1985-09-13 1986-09-03 Medikamentoese behandlungen. ATE67676T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB858522670A GB8522670D0 (en)	1985-09-13	1985-09-13	Drug treatments
EP86306823A EP0214839B1 (de)	1985-09-13	1986-09-03	Medikamentöse Behandlungen

Publications (1)

Publication Number	Publication Date
ATE67676T1 true ATE67676T1 (de)	1991-10-15

Family

ID=10585116

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT86306823T ATE67676T1 (de)	1985-09-13	1986-09-03	Medikamentoese behandlungen.

Country Status (10)

Country	Link
US (2)	US4996233A (de)
EP (1)	EP0214839B1 (de)
JP (1)	JP2588390B2 (de)
AT (1)	ATE67676T1 (de)
AU (1)	AU592593B2 (de)
CA (1)	CA1275249C (de)
DE (1)	DE3681667D1 (de)
GB (1)	GB8522670D0 (de)
IE (1)	IE59001B1 (de)
ZA (1)	ZA866743B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5599840A (en) *	1986-11-26	1997-02-04	Bar Ilan University	Physiologically active and nutritional composition
GB8805849D0 (en) *	1988-03-11	1988-04-13	Efamol Holdings	Porphyrins & cancer treatment
IL91802A (en) *	1988-10-27	1994-05-30	Univ Bar Ilan	Preparations containing linoleic acid history for the treatment of Alzheimer's, similar brain diseases, and epilepsy
US5219878A (en) *	1990-10-05	1993-06-15	Queen's University	Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
GB9301446D0 (en) *	1993-01-26	1993-03-17	Scotia Holdings Plc	Internal radiation damage
US5368841A (en) *	1993-02-11	1994-11-29	The General Hospital Corporation	Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
US5639460A (en) *	1995-06-07	1997-06-17	Raymond; Hal C.	Aqueous plant extract having antiviral activity
US7112609B2 (en) *	1999-06-01	2006-09-26	Drugtech Corporation	Nutritional supplements
FR2860720A1 (fr) *	2003-10-09	2005-04-15	Jean Pascal Conduzorgues	Nouvelles compositions pharmaceutiques pour traiter la xerostomie et maladies similaires
GB0907413D0 (en)	2009-04-29	2009-06-10	Equateq Ltd	Novel methods
US8293790B2 (en)	2011-10-19	2012-10-23	Dignity Sciences Limited	Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US9682055B2 (en)	2014-06-04	2017-06-20	Dignity Sciences Limted	Pharmaceutical compositions comprising DGLA and use of same
US20210315851A1 (en)	2020-04-03	2021-10-14	Afimmune Limited	Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2951014A (en) *	1957-01-03	1960-08-30	Upjohn Co	Process for a stable oil suspension
GB1014956A (en) *	1963-05-27	1965-12-31	Icar Ind Di Ricerca E Produzio	Compositions containing antibiotic compounds
US3988436A (en) *	1974-02-11	1976-10-26	Carnation Company	Sunscreening method using rice bran oil
US4461725A (en) *	1980-10-06	1984-07-24	Mitchell David C	Protein compounds
EP0071357B1 (de) *	1981-07-14	1985-01-02	Efamol Limited	Pharmazeutische und diätetische Zusammensetzung zur Erhöhung der Serie-l-Pg-Produktion
EP0092076B1 (de) *	1982-04-16	1986-12-17	Societe Des Produits Nestle S.A.	Lipidhaltige Zusammensetzung für die orale, enterale oder parenterale Ernährung
AU581840B2 (en) *	1982-09-27	1989-03-09	Health Research Inc.	Porphyrin derivatives
GB8302708D0 (en) *	1983-02-01	1983-03-02	Efamol Ltd	Pharmaceutical and dietary composition
DE3306912A1 (de) *	1983-02-26	1985-01-31	Joachim Dr. 7530 Pforzheim Hendus	Verwendung eines therapeutikums zur verhinderung der entstehung von urticaria solaris durch insolation
GB8429845D0 (en) *	1984-11-26	1985-01-03	Efamol Ltd	Porphyrins & cancer treatment
US4656186A (en) *	1985-04-30	1987-04-07	Nippon Petrochemicals Co., Ltd.	Tetrapyrrole therapeutic agents
DK168690B1 (da) *	1985-04-30	1994-05-24	Nippon Petrochemicals Co Ltd	Farmaceutiske præparater til detektion og/eller behandling af pattedyrtumorer
US4977177A (en) *	1985-04-30	1990-12-11	Nippon Petrochemicals Company, Ltd.	Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents

1985
- 1985-09-13 GB GB858522670A patent/GB8522670D0/en active Pending
1986
- 1986-09-02 IE IE235186A patent/IE59001B1/en not_active IP Right Cessation
- 1986-09-03 EP EP86306823A patent/EP0214839B1/de not_active Expired - Lifetime
- 1986-09-03 DE DE8686306823T patent/DE3681667D1/de not_active Expired - Fee Related
- 1986-09-03 AT AT86306823T patent/ATE67676T1/de active
- 1986-09-05 CA CA000517557A patent/CA1275249C/en not_active Expired - Fee Related
- 1986-09-05 ZA ZA866743A patent/ZA866743B/xx unknown
- 1986-09-10 AU AU62554/86A patent/AU592593B2/en not_active Ceased
- 1986-09-11 JP JP61212879A patent/JP2588390B2/ja not_active Expired - Lifetime
1990
- 1990-02-14 US US07/480,375 patent/US4996233A/en not_active Expired - Fee Related
1996
- 1996-03-06 US US08/611,525 patent/US5589509A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU592593B2 (en)	1990-01-18
US4996233A (en)	1991-02-26
US5589509A (en)	1996-12-31
EP0214839A3 (en)	1989-01-25
ZA866743B (en)	1987-04-29
GB8522670D0 (en)	1985-10-16
JPS6267021A (ja)	1987-03-26
CA1275249C (en)	1990-10-16
IE59001B1 (en)	1993-12-15
EP0214839A2 (de)	1987-03-18
JP2588390B2 (ja)	1997-03-05
IE862351L (en)	1987-03-13
EP0214839B1 (de)	1991-09-25
AU6255486A (en)	1987-03-19
DE3681667D1 (de)	1991-10-31

Publication	Publication Date	Title
ATE67676T1 (de)	1991-10-15	Medikamentoese behandlungen.
EP0303915A3 (en)	1990-08-08	Retinoids for the treatment of skin damaged by light
DE68905863D1 (de)	1993-05-13	Zusammensetzungen essentieller fettsaeuren.
ATE236627T1 (de)	2003-04-15	Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
NO940277L (no)	1994-07-28	Triglycerider og blandinger av slike
DK0663825T3 (da)	1999-05-25	Anvendelse af melatonin i orale doser til fremkaldelse af søvn
ES2060290T3 (es)	1994-11-16	Composiciones de acidos grasos esenciales (efa) y terapia.
MY101544A (en)	1991-12-17	Pharmaceutical composition for external use containing active-type vitamin d3.
TR200100457T2 (tr)	2001-08-21	Hayvan derisi ve mukozası üzerinde radyasyon terapisinin zarar verici etkilerinin düşürülmesi
DE3583887D1 (de)	1991-10-02	Ausruestung fuer die behandlung der osteoporose.
FI863976A0 (fi)	1986-10-01	Terapeutisk komposition.
ATE22533T1 (de)	1986-10-15	Pharmazeutische zusammensetzung.
ES2171535T3 (es)	2002-09-16	Producto nutritivo utilizado en el tratamiento de la colitis ulcerosa y su uso.
ATE164159T1 (de)	1998-04-15	Substituierte triole
ES2056983T3 (es)	1994-10-16	Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa.
ES8304058A1 (es)	1983-02-16	Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10,14-hexadecapentaenoico.
EP0248217A3 (en)	1989-11-08	Treatment of tumors with autologous lak cells, interleukin-2 and an ornithine decarboxylase inhibitor
SE7609145L (sv)	1977-03-18	Styrsystem for stromriktare
JPS5398730A (en)	1978-08-29	Input unit
ES2051788T3 (es)	1994-07-01	Un producto farmaceutico.
JPS51112154A (en)	1976-10-04	Pulse power source circuit
JPS53114274A (en)	1978-10-05	Emergency lighting device
JPS5241486A (en)	1977-03-31	Tasteful illuminating lamp
JPS5252381A (en)	1977-04-27	Power source
JPS5430454A (en)	1979-03-06	Reference voltage source circuit